(NVDA)

0.00

0.00 (0.00%)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Barcha huquqlar himoyalangan.

Foydalanish shartlari

(NVDA)

0.00

0.00 (0.00%)

28.03.2026

Investors Are Completely Wrong About Nvidia Stock

In this video, I will talk about Nvidia (NVDA 2.13%), the recent GTC news, and explain why the market is wrong. Watch the short video to learn more, consider subscribing, and click the special offer link below.

28.03.2026

Did Investors Get Too Far Ahead of the Artificial Intelligence (AI) Revolution? The Market Is Starting to Say Yes.

Artificial Intelligence is a powerful technology. The internet was a powerful technology.

28.03.2026

Iran Is Noise, Artificial General Intelligence Is The Signal, Nvidia Is The Trade

Nvidia Corporation's CEO claims AGI has been achieved. I argue the debate is irrelevant. What matters is that AI can now do a human's job, and the evidence is mounting. Historical productivity data suggests AGI could drive US GDP growth rates not seen since the post-WWII era. GPU demand is not peaking; each new AI phase (agentic, edge, physical AI) generates additional chip demand, reinforcing Nvidia's position.

28.03.2026

$10,000 in XRP and Bitcoin vs $10,000 in Nvidia: What Each Could Be Worth by the End of 2026

Nvidia ( NASDAQ: NVDA | NVDA Price Prediction ) turned every $10,000 invested in early 2023 into over $125,000 by late 2025—a return that made it the most talked-about stock on the planet.

28.03.2026

3 Artificial Intelligence (AI) Stocks to Buy at a Discount

Micron just doubled its revenue quarter over quarter. Nvidia still sees massive demand for its GPUs.

28.03.2026

Why Nvidia (NVDA) stock could be offering a generational buying opportunity

Although Nvidia (NASDAQ: NVDA) stock is currently witnessing a sustained sell-off, technical indicators suggest the equity is at a critical inflection point that could determine its next direction.

28.03.2026

What Moved Markets This Week

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.

Videolar

No Data

There is no data to display

Press-relizlar

27.03.2026

BetterInvesting™ Magazine Update on NVIDIA Corp. (NASDAQ: NVDA) and Tennant Company (NYSE: TNC)

TROY, Mich., March 27, 2026 /PRNewswire/ -- NVIDIA Corp.'s recent report has investors wondering if the company's stock is fairly valued.

27.03.2026

Lexlegis Showcases Legal AID at NVIDIA GTC 2026; Announces U.S. Beta Launch, Signals Rise of the ‘Legal Intelligence Factory'

SAN JOSÉ, Calif., March 27, 2026 (GLOBE NEWSWIRE) -- Lexlegis, an AI-first legal technology company, marked a significant global milestone at NVIDIA GTC 2026, unveiling its advanced legal AI platform Legal AID – Ask, Interact, Draft and announcing the preview beta launch of Lexlegis USA, its official entry into the United States market.

26.03.2026

FPT AI Factory Accelerates AI Reasoning Capabilities across Southeast Asia and Japan with NVIDIA

HANOI, Vietnam--(BUSINESS WIRE)-- #AIFactory--FPT AI Factory announced the buildout of its next-generation AI infrastructure, accelerated by NVIDIA HGX B300 systems. This marks a significant milestone in empowering AI developers and enterprises to advance AI innovation across the region with reasoning and agentic capabilities. AI is shifting into a new phase where its true value will be defined by how deeply it is embedded into the fabric of industries. As models grow more powerful and adoption accelerates,.

24.03.2026

KeyCare Deploys NVIDIA Nemotron to Power AI-Driven Clinical Intake at Scale

CHICAGO--(BUSINESS WIRE)-- #AIinHealthcare--KeyCare, the only national Epic-based virtual care group, today announced the deployment of NVIDIA's Nemotron large language model in production to power its AI-driven patient intake agent. KeyCare selected Nemotron for its strong reasoning performance, consistency, and suitability for real-world clinical workflows. KeyCare's Intake Agent, which is embedded in KeyCare's virtual waiting room, adapts in real time based on the patient's reason for visit, summarizing clini.